These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8996720)

  • 1. Differentiation of Proteus mirabilis and Proteus vulgaris strains by means of proticine typing: a longitudinal epidemiological study.
    Sekaninová G; Kolárová M
    Cent Eur J Public Health; 1996 May; 4(2):98-101. PubMed ID: 8996720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nosocomial infections caused by selected gram-negative bacteria at the Anaesthesiology and Intensive Care Unit of the Teaching Hospital in Brno.
    Sekaninová G; Kolárová M; Semrádová S; Táborská D; Zajícová V
    Cent Eur J Public Health; 1995 May; 3(2):80-3. PubMed ID: 7655409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proticine typing of serologically defined Proteus strains.
    Csiszár K; Lányi B
    Acta Microbiol Acad Sci Hung; 1981; 28(1):111-8. PubMed ID: 7020353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the usefulness of standard strains sets from the senior collection for typing Proteus mirabilis strains].
    Aleksandrowicz I; Samet A
    Med Dosw Mikrobiol; 1994; 46(4):285-91. PubMed ID: 7603129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of hospital strains of Proteus mirabilis by the methods of proticine and bacteriophage typing].
    Zawieja M
    Med Dosw Mikrobiol; 1988; 40(4):213-8. PubMed ID: 3073282
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug resistance and proticinogenic types of Proteus mirabilis isolated from urinary tract infections].
    Szymaniak L; Aleksandrowicz I; Giedrys-Kalemba S
    Med Dosw Mikrobiol; 1999; 51(3-4):323-30. PubMed ID: 10803261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A highly discriminatory multi-typing scheme for Proteus mirabilis and Proteus vulgaris.
    Senior BW; Larsson P
    J Med Microbiol; 1983 May; 16(2):193-202. PubMed ID: 6188832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ability of a Proteus mirabilis strain to invade the bloodstream is independent of its proticine production/proticine sensitivity type.
    Senior BW
    J Med Microbiol; 1997 May; 46(5):407-12. PubMed ID: 9152037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Typing of Proteus strains by proticine production and sensitivity.
    Senior BW
    J Med Microbiol; 1977 Feb; 10(1):7-17. PubMed ID: 320341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separate O-grouping schemes for serotyping clinical isolates of Proteus vulgaris and Proteus mirabilis.
    Penner JL; Hennessy JN
    J Clin Microbiol; 1980 Sep; 12(3):304-9. PubMed ID: 7012166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of particular types of Proteus with chronic suppurative otitis media.
    Senior BW; Sweeney G
    J Med Microbiol; 1984 Apr; 17(2):201-5. PubMed ID: 6368831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Response to antibiotics of Proteus strains isolated from different types of clinical material].
    Ovetchin PV; Tsyganenko AIa
    Antibiotiki; 1984 Apr; 29(4):272-5. PubMed ID: 6378080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and serological properties of the O-antigen of two clinical Proteus mirabilis strains classified into a new Proteus O77 serogroup.
    Drzewiecka D; Arbatsky NP; Shashkov AS; Staczek P; Knirel YA; Sidorczyk Z
    FEMS Immunol Med Microbiol; 2008 Nov; 54(2):185-94. PubMed ID: 18665848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients.
    Saito R; Okugawa S; Kumita W; Sato K; Chida T; Okamura N; Moriya K; Koike K
    Clin Microbiol Infect; 2007 Dec; 13(12):1204-6. PubMed ID: 17850340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotyping of clinical isolates belonging to Proteus mirabilis serogroup O36 and structural elucidation of the O36-antigen polysaccharide.
    Arabski M; Grabowski S; Konieczna I; Kaca W; Kondakova AN; Perepelov AV; Senchenkova SN; Shashkov AS; Knirel YA
    FEMS Immunol Med Microbiol; 2008 Aug; 53(3):395-403. PubMed ID: 18625011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological analysis of Pseudomonas aeruginosa strains isolated from a selected patient population in Brno, Czech Republic.
    Sekaninová G; Kolárová M; Seménka J; Zajícová V; Burgetová D; Svoboda J; Svihálková A
    Cent Eur J Public Health; 1999 Aug; 7(3):140-4. PubMed ID: 10499146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The special affinity of particular types of Proteus mirabilis for the urinary tract.
    Senior BW
    J Med Microbiol; 1979 Feb; 12(1):1-8. PubMed ID: 372530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of epidemiological methods for differentiation of Proteus mirabilis.
    Kusek JW; Herman LG
    Am J Med Technol; 1981 Oct; 47(10):835-40. PubMed ID: 7036744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of bacteriocinogenic types of strains of Proteus mirabilis].
    Józefowicz-Piatkowska H; Piatkowski K
    Med Dosw Mikrobiol; 1994; 46(3):151-60. PubMed ID: 7996932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection.
    Khan AU; Musharraf A
    Med Sci Monit; 2004 Nov; 10(11):CR598-602. PubMed ID: 15507850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.